Description

The collaborative is an ad hoc activity convened under the auspices of the Forum on Neuroscience and Nervous System Disorders at the National Academies of Sciences, Engineering, and Medicine (the National Academies). The work it produces does not necessarily represent the views of any one organization, the Forum, or the National Academies, and is not subjected to the review procedures of, nor is it a report or product of, the National Academies.

Despite implantable brain stimulation’s increased usage in clinical care, there remains unaddressed barriers to fully adopting implantable brain stimulation into the standard of care in for central nervous system disorders. To better understand the current state of clinical utilization, patient and physician education, and economic considerations, on October 31, 2023 the National Academies of Sciences, Engineering, and Medicine's Forum on Neuroscience and Nervous System Disorders hosted the workshop, Exploring the Adoption of Implantable Brain Stimulation into Standard of Care for Central Nervous System Disorders, to explore the challenges and potential pathways forward to advance the field.

The workshop highlighted strategies and opportunities for different groups to advance the adoption of implantable brain stimulation. While the perspectives of some groups were considered at the workshop, not all were. Therefore, this collaborative aims to engage a broader range of communities who could have different perceived barriers to adoption.

Collaborative Activities

The goal of this action collaborative, an ad hoc activity associated with the National Academies’ Forum on Neuroscience and Nervous System Disorders, is to hear from different communities (e.g., professional societies, community physicians, individuals with lived experience, and payers) about their perceived barriers to adoption and share takeaways from the workshop through a series of informal facilitated conversations .

Collaborative Members

Helen Mayberg, M.D., (chair), Icahn School of Medicine at Mount Sinai

Tim Denison, Ph.D., M.S., University of Oxford

Nita Farahany, J.D., Ph.D., Duke University

Holly Lisanby, M.D., National Institute of Mental Health

Brian Litt, M.D., University of Pennsylvania

Laura Lubbers, Ph.D., CURE Epilepsy

David McMullen, M.D., U.S. Food and Drug Administration

Jim McNasby, J.D., The Michael J. Fox Foundation for Parkinson’s Research

Martha Morrell, M.D., F.A.A.N., NeuroPace, Inc

John Ngai, Ph.D., NIH BRAIN Initiative

Yagna Pathak, Ph.D., Abbott

Sarah Perides, M.Sc., Evelina London Children’s Hospital

Khara Ramos, Ph.D., Dana Foundation

Katie Sales, American Brain Coalition

Rita Valentino, Ph.D., National Institute on Drug Abuse

Alik Widge, M.D., Ph.D., University of Minnesota